Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[age]	Characteristics[developmental stage]	Characteristics[cell line]	Characteristics[cell type]	Characteristics[ancestry category]	Characteristics[sex]	Characteristics[disease]	Characteristics[individual]	assay name	Technology Type	comment[label]	comment[file uri]	comment[instrument]	comment[fractionation method]	comment[fraction identifier]	comment[separation]	comment[dissociation method]	comment[collision energy]	comment[cleavage agent details]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[data file]	Material Type	factor value[organism part]
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC16	run 1	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110819_EXQ4_TaGe_SA_PC_16_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ4_TaGe_SA_PC_16_2.raw	tissue	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC16	run 2	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110819_EXQ4_TaGe_SA_PC_16_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ4_TaGe_SA_PC_16_3.raw	tissue	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC16	run 3	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110819_EXQ4_TaGe_SA_PC_16_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ4_TaGe_SA_PC_16_4.raw	tissue	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC16	run 4	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110819_EXQ4_TaGe_SA_PC_16_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ4_TaGe_SA_PC_16_5.raw	tissue	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC16	run 5	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110819_EXQ4_TaGe_SA_PC_16_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ4_TaGe_SA_PC_16_6.raw	tissue	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC17	run 6	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110819_EXQ4_TaGe_SA_PC_17_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ4_TaGe_SA_PC_17_1.raw	tissue	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC17	run 7	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110819_EXQ4_TaGe_SA_PC_17_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ4_TaGe_SA_PC_17_2.raw	tissue	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC17	run 8	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110819_EXQ4_TaGe_SA_PC_17_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ4_TaGe_SA_PC_17_3.raw	tissue	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC17	run 9	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110819_EXQ4_TaGe_SA_PC_17_4_110824001101.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ4_TaGe_SA_PC_17_4_110824001101.raw	tissue	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC17	run 10	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110819_EXQ4_TaGe_SA_PC_17_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ4_TaGe_SA_PC_17_5.raw	tissue	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC17	run 11	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110819_EXQ4_TaGe_SA_PC_17_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ4_TaGe_SA_PC_17_6.raw	tissue	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC7	run 12	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110822_EXQ3_TaGe_SA_PC7_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110822_EXQ3_TaGe_SA_PC7_1.raw	tissue	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC7	run 13	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110822_EXQ3_TaGe_SA_PC7_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110822_EXQ3_TaGe_SA_PC7_2.raw	tissue	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC7	run 14	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110822_EXQ3_TaGe_SA_PC7_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110822_EXQ3_TaGe_SA_PC7_3.raw	tissue	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC7	run 15	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110822_EXQ3_TaGe_SA_PC7_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110822_EXQ3_TaGe_SA_PC7_4.raw	tissue	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC7	run 16	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110822_EXQ3_TaGe_SA_PC7_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110822_EXQ3_TaGe_SA_PC7_5.raw	tissue	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC7	run 17	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110822_EXQ3_TaGe_SA_PC7_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110822_EXQ3_TaGe_SA_PC7_6.raw	tissue	prostate tumors tissue
Sample 4	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC2	run 18	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110826_EXQ4_TaGe_sa_PC2_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110826_EXQ4_TaGe_sa_PC2_1.raw	tissue	non-malignant prostate tissue
Sample 4	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC2	run 19	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110826_EXQ4_TaGe_sa_PC2_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110826_EXQ4_TaGe_sa_PC2_2.raw	tissue	non-malignant prostate tissue
Sample 4	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC2	run 20	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110826_EXQ4_TaGe_sa_PC2_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110826_EXQ4_TaGe_sa_PC2_3.raw	tissue	non-malignant prostate tissue
Sample 4	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC2	run 21	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110826_EXQ4_TaGe_sa_PC2_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110826_EXQ4_TaGe_sa_PC2_4.raw	tissue	non-malignant prostate tissue
Sample 4	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC2	run 22	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110826_EXQ4_TaGe_sa_PC2_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110826_EXQ4_TaGe_sa_PC2_5.raw	tissue	non-malignant prostate tissue
Sample 4	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC2	run 23	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD004132/20110826_EXQ4_TaGe_sa_PC2_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110826_EXQ4_TaGe_sa_PC2_6.raw	tissue	non-malignant prostate tissue
